Halozyme Therapeutics (HALO) Intangibles (2022 - 2026)
Halozyme Therapeutics (HALO) posted Intangibles of $922.44 million for Q2 2026, up 151.8% from $366.31 million a year earlier but down 3.1% from the prior quarter.
Halozyme Therapeutics (HALO) Intangibles (2022 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics' Intangibles came in at $981.47 million, up 144.2% from FY2024.
- Annual Intangibles shows a three-year compound annual growth rate of 21.5% (FY2022 to FY2025).
- In prior years, Halozyme Therapeutics' Intangibles was $401.83 million in FY2024 (-15.0%), $472.88 million in FY2023 (-13.5%) and $546.65 million in FY2022.
- Quarterly Intangibles has run from a low of $348.54 million in Q3 2025 to a high of $981.47 million in Q4 2025 over five years.
- On a year-over-year basis, Intangibles has increased in each of the last three quarters, with growth averaging 45.7% over the last eight quarters.
- The strongest year-over-year quarter for Intangibles in the past five years was Q2 2026, with growth of 151.8%; the weakest was Q3 2023, with a decline of 48.3%.
- According to Business Quant data, Intangibles for the three prior quarters was $951.96 million (Q1 2026), $981.47 million (Q4 2025) and $348.54 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 56.65 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 24.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 11.80 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 38.15 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 19.54 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.42 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 45.96 Bn |
| 10 | Halozyme Therapeutics | 11.73 Bn | 9.97 Bn | 410.50 Mn | 892.93 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 892.93 Mn |
| Jun 30, 2026 | 922.44 Mn |
| Mar 31, 2026 | 951.96 Mn |
| Dec 31, 2025 | 981.47 Mn |
| Sep 30, 2025 | 348.54 Mn |
| Jun 30, 2025 | 366.31 Mn |
| Mar 31, 2025 | 384.07 Mn |
| Dec 31, 2024 | 401.83 Mn |
| Sep 30, 2024 | 419.59 Mn |
| Jun 30, 2024 | 437.35 Mn |
| Mar 31, 2024 | 455.12 Mn |
| Dec 31, 2023 | 472.88 Mn |
| Sep 30, 2023 | 490.64 Mn |
| Jun 30, 2023 | 510.98 Mn |
| Mar 31, 2023 | 528.82 Mn |
| Dec 31, 2022 | 546.65 Mn |
| Sep 30, 2022 | 948.90 Mn |
| Jun 30, 2022 | 976.10 Mn |
Halozyme Therapeutics Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=HALO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();